Healthy Debut: Park Medi World Lists with Modest Premium Signals

The IPO attracted strong interest from Qualified Institutional Buyers (QIBs) and Non-Institutional Investors (NIIs), while retail participation was moderate. Proceeds from the issue will be used for expansion of hospital facilities, debt repayment, and general corporate purposes. Experts note that while subscription strength supports investor confidence, GMP signals a restrained debut amid broader market volatility.  

Notable updates  
• Park Medi World IPO size: ₹920 crore with ₹154–₹162 price band  
• Subscription: 8.52x overall; QIB 12.07x, NII 15.93x, retail 3.32x  
• GMP: ~₹5.5, implying listing near ₹167.5 (3–4% premium)  
• Listing date: December 17, 2025, on BSE and NSE  
• Funds to be used for expansion, debt reduction, and corporate needs  

Major takeaway  
Park Medi World’s listing reflects strong institutional backing but a cautious premium, highlighting investor focus on execution and growth post-listing.  

Sources: LiveMint, CNBC-TV18, Goodreturns, Chittorgarh